National Influenza Vaccine Summit. Atlanta April 12, 2008 Mitch Johnson

GSK commitment to influenza prevention

GSK commitment to influenza prevention Dr Catia Ferreira Influenza Portfolio US Medical Affairs Leader GSK Vaccines GSK commitment to Influenza Rixensart (Belgium) Shenzhen (China) Marietta (US) Saint-Amand

U.S. Readiness for Pandemics

0 U.S. Readiness for Pandemics 5 th National Emergency Management Summit Brooklyn, NY September 15, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary for Preparedness & Response (HHS/ASPR) Director

Vaccine* Presentation Age Group (Indication) 0.5-mL prefilled, single-dose syringe. syringe 5-mL multidose vial (ten 0.5-mL doses)

GSK Flu 2018 Update Luis Romano, MD US Medical Affairs Director Influenza Vaccines May 18, 2018 Simplifying flu vaccination for providers With the FDA approval of an expanded indication for FLUARIX QUADRIVALENT

Annual Influenza Review

Annual Influenza Review 2017-2018 A review of past flu trends and what to expect in the coming season. Count on Our Support, Educational Resources and Products to Help You Prepare for the Next Influenza

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect

H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009

August 6, 2009 H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009 CDC s Advisory Committee on Immunization Practices (ACIP), a panel made up of medical and public health experts, met July 29, 2009,

GENERAL SAFETY ISSUES September 18, 2009

Is the 2009 H1N1 influenza vaccine safe? GENERAL SAFETY ISSUES September 18, 2009 We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have a very

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

On behalf of the Infectious Diseases Society of America (IDSA), I am pleased to provide

Transmitted by Jonathan Nurse, Director of Government Relations, IDSA The Infectious Diseases Society of America s (IDSA) Fiscal Year 2015 Funding Statement Submitted to the House Appropriations Subcommittee

General Questions and Answers on 2009 H1N1 Influenza Vaccine Safety

General Questions and Answers on 2009 H1N1 Influenza Vaccine Safety October 5, 2009, 12:00 PM ET Will the 2009 H1N1 influenza vaccines be safe? We expect the 2009 H1N1 influenza vaccine to have a similar

PURCHASING MEMORANDUM

NUMBER: CL-602 DATE: March 3, 2005 Pricing Clarification MMCAP has received several calls concerning the prices invoiced for vaccine received during the current flu season. All orders filled by Aventis

Influenza Vaccine Questions and Answers. Influenza Control Program

Influenza Vaccine Questions and Answers Influenza Control Program Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected

Influenza vaccination rates are still below public health goals

GSK Influenza Vaccines Update Luis Romano, MD Medical Affairs Director Influenza Vaccines, GSK Influenza vaccination rates are still below public health goals Early season and end of season flu vaccination

Q2034 And The New Flu Shot Medicare Reimbursement Codes

Q2034 And The New 2012 2013 Flu Shot Medicare Reimbursement Codes 9/29/2012 Medicare pricing just released for flu shots see pricing added to the codes below. Download this excellent 2012 2013 grid that

GSK s Candidate Influenza A (H5N1) Virus Monovalent Vaccine

GSK s Candidate Influenza A (H5N1) Virus Monovalent Vaccine Regulatory Pathway for Licensure VRBPAC, February 29, 2012 Katalin Abraham, Director, US Regulatory Affairs GSK Biologicals GSK s Influenza Vaccines

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

Full Season Immunization: A New Paradigm Is Evolving Update

Full Season Immunization: A New Paradigm Is Evolving 28 Update Why Is a New Paradigm Needed? It is medically relevant to vaccinate throughout the entire influenza season Influenza immunization recommendations

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine. since 2006

Industry Perspective: Strategies and costs associated with increasing seasonal influenza vaccine use from high to low income countries since 2006 Dr. Michael Watson, sanofi-pasteur on behalf of WHO GAP

Novel H1N1 Influenza Vaccine

Novel H1N1 Influenza Vaccine Vaccine Supply and Distribution 1) When will the 2009 novel H1N1 influenza vaccine be available? Limited amounts of the novel H1N1 vaccine are expected to be available in mid-

FLU VACCINE MYTHS & FACTS. Get the facts to keep you and your loved ones flu-free. Sponsored by:

FLU VACCINE MYTHS & FACTS Get the facts to keep you and your loved ones flu-free. Sponsored by: The flu isn t that serious... Many people are unaware that influenza, the flu, is a serious disease. According

H1N1 Disease & Vaccine in Maryland

H1N1 Disease & Vaccine in Maryland A Webcast for Registered Vaccine Providers October 22, 2009 E-mail Questions to: maphtc@jhsph.edu 1 Program & Panel Presenters Introductory Remarks:- John M. Colmers,

Health Care Personnel Vaccination in the Long Term Care Setting

Health Care Personnel Vaccination in the Long Term Care Setting Jennifer Heath, DNP, MPH, RN Objectives Interpret current influenza recommendations as they pertain to health care personnel (HCP) in the

1. Introduction. Page 1. Preparation for the Influenza Season:

1. Introduction Preparation for the 2015-2016 Influenza Season: The purpose of this survey is to aid in estimating influenza vaccine needs for VFC-eligible and PeachCare for Kids patients in your facility.

Pandemic lessons learnt

Pandemic lessons learnt PCWP-HCPWG Joint meeting 28 February 2012 Presented by: Ragini Shivji, Monika Benstetter EMA An agency of the European Union Overview of presentation Background & Objective European

Pandemic Influenza: Appropriations for Public Health Preparedness and Response

Order Code RS22576 January 23, 2007 Pandemic Influenza: Appropriations for Public Health Preparedness and Response Summary Sarah A. Lister Specialist in Public Health and Epidemiology Domestic Social Policy

Transforming The Approach to Vaccines and Protein- Based Therapeutics. Alain Doucet, Ph.D. Manager, Process Development, Medicago

Transforming The Approach to Vaccines and Protein- Based Therapeutics Alain Doucet, Ph.D. Manager, Process Development, Medicago 2018-08-15 1 Medicago Overview 2 Novel Technologies 3 Robust Pipeline 2

H1N1 Planning, Response and Lessons to Date

H1N1 Planning, Response and Lessons to Date Glen Nowak, Ph.D. Acting Director Division of News and Electronic Media Centers for Disease Control and Prevention The Beginning Mid-April indications that we

Quadrivalent Flu Vaccines: Four Means More Protection

Quadrivalent Flu Vaccines: Four Means More Protection By Keith Berman, MPH, MBA, and Luke Noll AHEAD OF EACH flu season, experts at the U.S. Food and Drug Administration (FDA) and the World Health Organization

DRAFT WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE WGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE GETREADYNOWGE.

What Can I Do As A National Leader? This publication was produced by the AI.COMM project, managed by the Academy for Educational Development (AED), and funded by the U.S. Agency for International Development

Pandemic Influenza Planning at Kaiser Permanente

Pandemic Influenza Planning at Kaiser Permanente Skip Skivington, MBA Interim Vice President of Supply Chain Kaiser Foundation Health Plan, Inc. Eric Koscove, MD Emergency Medicine Santa Clara Medical

Influenza Virus. Influenza A virus. Influenza B virus. Influenza C virus

Outline Influenza Virus Population Data Vaccination Rates 2010-11 Influenza Vaccines Live Attenuated Influenza Vaccine (LAIV) High-Dose Trivalent Inactivated Vaccine (HD TIV) Influenza Virus Influenza

Pandemic Flu Impact in U.S.

Pandemic Flu Impact in U.S. Pandemic Flu and the Potential for U.S. Economic Recession Second worst recession since World War II -- about 5.25% decline in Gross Domestic Product (GDP); $683 billion loss

Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06)

Questions and Answers Regarding Federal Contracts for State-Purchased Antiviral Drugs (Relenza & Tamiflu ) (07/26/06) These questions were received in response to the recently executed contracts with Roche

Fact Sheet Flu Vaccine Crisis: The Administration s Response to Recommendations and Warnings

REP. HENRY A. WAXMAN RANKING MINORITY MEMBER COMMITTEE ON GOVERNMENT REFORM U.S. HOUSE OF REPRESENTATIVES OCTOBER 18, 2004 Fact Sheet Flu Vaccine Crisis: The Administration s Response to Recommendations

9/14/12. IDSA Pandemic and Seasonal Influenza: Principles for U.S. Action. Prediction is very difficult, especially about the future

IDSA Pandemic and Seasonal Influenza: Principles for U.S. Action Andrew T. Pavia M.D. Chair IDSA Pandemic Influenza Task Force George and Esther Gross Presidential Professor Chief Division of Pediatric

SANOFI PASTEUR, LEADING PROVIDER OF SEASONAL INFLUENZA VACCINES

FACT SHEET SANOFI PASTEUR, LEADING PROVIDER OF SEASONAL INFLUENZA VACCINES WORLD S LEADING INFLUENZA VACCINE MANUFACTURER Annual production capacity of Sanofi Pasteur seasonal influenza vaccines have doubled

Advancing Pandemic Preparedness through APSED III

Advancing Pandemic Preparedness through APSED III Masaya Kato Programme Area Manager Country Health Emergency Preparedness and the IHR (CPI) WHO Health Emergencies Programme (WHE) WHO Western Pacific Regional

Pandemic Influenza Planning:

Pandemic Influenza Planning: Get Information. Stay Informed. U.S. Department of Health and Human Services May 2006 While the Federal Government will use all resources at its disposal to prepare for and

Outline. Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1

Outline Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1 National & State Statistics Lessons from Past Pandemics Vaccination & Treatment Strategies Influenza Virus Influenza

H1N1 Update. What is a flu pandemic? 12/7/2009. PCAST - President s Council of Advisors On Science And Technology

H1N1 Update Greg Dworkin, MD Chief, Pediatric Pulmonology Danbury Hospital Nov 20, 2009 https://webmeeting.nih.gov/p12358385/ PCAST - President s Council of Advisors On Science And Technology What is a

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)

Community Pharmacy-based Immunization

Community Pharmacy-based Immunization Sara Rubin, MPH, MA Manager, Pharmacy Care srubin@nacds.org Defining Chain Pharmacy Operates more than 41,000 pharmacies Employs more than 3.8 million employees, including

Developing a Target Product Profile for a Preventive HIV Vaccine

Developing a Target Product Profile for a Preventive HIV Vaccine Topics to be Covered Overview of TPPs What are they? What is the purpose and benefit of using a TPP? What is usually in a TPP? What are

Pandemic Preparedness 4th New Zealand Influenza Symposium. 8 February 2018 Charles Blanch, Director Emergency Management

Pandemic Preparedness 4th New Zealand Influenza Symposium 8 February 2018 Charles Blanch, Director Emergency Management Cathedral Square, Christchurch NZ, Hastings Airfield Ebola Treatment Centre, Sierra

Pandemic Influenza Preparedness and Response

Pandemic Influenza Preparedness and Response US Department of Health and Human Services Bruce Gellin, MD, MPH Director, National Vaccine Program Office The pandemic influenza clock is ticking. We just

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

CONTAGIOUS COMMENTS Department of Epidemiology

VOLUME XXXIII NUMBER 4 September 2018 CONTAGIOUS COMMENTS Department of Epidemiology Influenza Vaccination Suchitra Rao, MBBS and Jason Child, PharmD New influenza vaccines have arrived. It is important

H1N1-A (Swine flu) and Seasonal Influenza

H1N1-A (Swine flu) and Seasonal Influenza Influenza, commonly known as the flu, is a contagious viral disease that typically occurs in the winter months and causes cough, fever, sore throat, headache,

FluMist Update (Influenza Virus Vaccine Live, Intranasal)

FluMist Update (Influenza Virus Vaccine Live, Intranasal) National Influenza Vaccine Summit Kathleen Coelingh, PhD Senior Director, Medical and Scientific Affairs June 29, 2009 Dallas, TX 2009-10 Seasonal

SPECIAL ISSUE. brief WINTER Flu Prevention and Response Planning. By Brett Lee and Colleen Honnors, RN, BSN

SPECIAL ISSUE brief WINTER 2018 Flu Prevention and Response Planning By Brett Lee and Colleen Honnors, RN, BSN SPECIAL ISSUE BRIEF WINTER 2018 2018 The American Seniors Housing Association All rights reserved.

Serum Institute of India Ltd. The Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV])

Nasovac The Nasal-Spray Flu Vaccine (Live Attenuated Influenza Vaccine [LAIV]) Questions & Answers Who can be vaccinated with the nasal-spray flu vaccine LAIV (Nasovac )? LAIV (Nasovac ) is approved for

REVISIONS: Strategies to Achieve the Healthy People 2020 Annual Goal of 90% Influenza Vaccination Coverage for Health Care Personnel

National Vaccine Advisory Committee Health Care Personnel Influenza Vaccination Subgroup REVISIONS: Strategies to Achieve the Healthy People 2020 Annual Goal of 90% Influenza Vaccination Coverage for Health

Minnesota s Preparations for H1N1 Influenza. Sanne Magnan, MD, PhD Minnesota Department of Health September 23, 2009

Minnesota s Preparations for H1N1 Influenza Sanne Magnan, MD, PhD Minnesota Department of Health September 23, 2009 H1N1 Cases in Minnesota: Preliminary Data as of Sept. 21, 2009 281 hospitalized cases

GAO INFLUENZA VACCINE. Issues Related to Production, Distribution, and Public Health Messages

GAO United States Government Accountability Office Report to the Committee on Oversight and Government Reform, House of Representatives October 2007 INFLUENZA VACCINE Issues Related to Production, Distribution,

Gaps in Influenza Clinical Research. Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program

Gaps in Influenza Clinical Research Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program Outline 1. Global frameworks: 2010 Research Agenda 2013 BRaVe Agenda 2.

NEEDLE-FREE INJECTION SAFE. EASY. NO NEEDLE.

Stratis NEEDLE-FREE INJECTION SAFE. EASY. NO NEEDLE. COMPANY OVERVIEW Based in Golden, Colorado, PharmaJet s mission is worldwide acceptance of PharmaJet Needle- Free devices as a standard of care in the

Vaccine Administration Considerations

CHAPTER 1 Vaccine Administration Considerations While the majority of cases of serious illness and death from influenza occur primarily in high-risk persons (those older than 65, children younger than

Michel BAIJOT Vice President, WW Business Development & Strategic Alliances

Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

University of Colorado Denver Pandemic Preparedness and Response Plan April 30, 2009 UCD Pandemic Preparedness and Response Plan Executive Summary The World Health Organization (WHO) and the Centers for

FluSafe: Tool for Tracking Healthcare Worker Immunizations in IIS

FluSafe: Tool for Tracking Healthcare Worker Immunizations in IIS Aaron Bieringer Data Quality Analyst, MIIC Program September 20, 2012 Outline FluSafe Overview Current Process Proposed Enhancements Next

Making Life Better UNIVERSITY OF SOUTH FLORIDA

Making Life Better UNIVERSITY OF SOUTH FLORIDA MCOL UNIV Making Life Better CO UN Disclosures I have no financial, personal, or familial associations to disclose What is a Vaccine? Agent stimulates the

School-based Seasonal Influenza (flu) Vaccinations Frequently Asked Questions Parents/Guardians

School-based Seasonal Influenza (flu) Vaccinations Frequently Asked Questions Parents/Guardians 1) Why are school children being offered free flu vaccine? The Hawai i State Department of Health (DOH) believes

Navigating Options for Influenza Immunization, What a difference a decade makes 2004

Navigating Options for Influenza Immunization, 2013-2014 What a difference a decade makes 2004 Disclosures No financial conflicts of interest May discuss off-label use of influenza vaccines during presentation

New Jersey Dept. of Health and Senior Services Public Information. Date: September 22, 2009 Time: 12:00 AM. H1N1 Vaccination Program

2009 H1N1 INFLUENZA New Jersey Dept. of Health and Senior Services Public Information Date: September 22, 2009 Time: 12:00 AM H1N1 Vaccination Program 1. What is novel H1N1 (swine flu)? Novel H1N1 (referred

Influenza: Questions and Answers

Influenza: Questions and Answers Information about the disease and vaccines What causes influenza? Viruses cause influenza. There are two basic types, A and B. Their genetic material differentiates them.

Update on A(H1N1) pandemic and seasonal vaccine availability. July 7, 2009

Update on A(H1N1) pandemic and seasonal vaccine availability July 7, 2009 Presentation objectives and approach Presentation Objectives Review production status for 2009-2010 Northern Hemisphere vaccine

CDC Prepares Special Issue August 2006

CDC Prepares Special Issue August 2006 Fast Facts CDC s Influenza Pandemic Operation Plan The final draft of CDC s Influenza Pandemic Operation Plan has been completed and includes more than 1600 specific

Multi-sectoral aspects of pandemic preparedness and response

Multi-sectoral aspects of pandemic preparedness and response Best practices, challenges and lessons learned in the EU International Ministerial Conference on Avian & Pandemic Influenza Sharm el Sheikh,

Pandemic Preparation in the Commonwealth. Mass Health Policy Forum 6/8/06

Pandemic Preparation in the Commonwealth Mass Health Policy Forum 6/8/06 Our Goal When the pandemic has passed, and the impact of the wave recedes, we will be able to look back and know: That the Commonwealth

New York State Department of Health. Notice of Voluntary Recall of Influenza A (H1N1) 2009 Monovalent Vaccine

New York State Department of Health Notice of Voluntary Recall of Influenza A (H1N1) 2009 Monovalent Vaccine The U.S. Centers for Disease Control and Prevention have announced a Non safety Related Voluntary

Influenza A H1N1 Swine Flu Update:

Influenza A H1N1 Swine Flu Update: Pandemic Influenza Planning for the Workplace Current as of August 2009 Georgia Tech OSHA Consultation Program This course does not necessarily reflect the views or policies

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH CSAPH Report 5-I-12 Subject: Presented by: Referred to: AMA Policy Consolidation: Influenza and Influenza Vaccine Sandra A. Fryhofer, MD, Chair Reference

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE

PROMOTING AN EFFECTIVE MEDICAL COUNTERMEASURES ENTERPRISE Gerald R. Kovacs, PhD Director, Division of Chem/Bio/Rad/Nuc Medical Countermeasures Biomedical Advanced Research and Development Authority Assistant

Stockpiling of H5N1 vaccines

Stockpiling of H5N1 vaccines Norbert W. Hehme EVM Influenza Pandemic Working Group EU-Commission Workshop on Stockpiling of Medicinal Products February 21/22, 2008 European Vaccine Manufacturers 1 (EVM)

Influenza Season Education

2016-2017 Influenza Season Education What is Influenza (Flu) Influenza is an infection that is caused by a flu virus. There are many different types of flu viruses The flu affects the lungs, throat, nose,

What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer and Medical Director of Communicable Disease Control

Vancouver Coastal Health & The Vancouver Coastal Health Research Institute presents: On Call with VGH Experts Lecture Series The Flu and You What is Influenza? Patricia Daly MD, FRCPC Medical Health Officer

FY2018 Labor, Health and Human Services, Education Appropriations Summary

Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health

November 13, 2009 Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine By Matthew Watson and Jennifer Nuzzo

www.upmc-biosecurity.org www.upmc-cbn.org November 13, 2009 Licensure, Evaluation, and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine By Matthew Watson and Jennifer Nuzzo In response to the

Flu season is near. Are you at risk?

Flu season is near Are you at risk? D New for 2007 Children under age 9 receiving an influenza vaccination for the first time need two doses approximately one month apart. Children between the ages of

Flu Vaccines for

This Clinical Resource gives subscribers additional insight related to the Recommendations published in October 2018 ~ Resource #341001 Flu Vaccines for 2018-2019 CDC has released recommendations for influenza

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American

What Antivirals Can Be Used for 2009 H1N1 Influenza?

www.upmc-biosecurity.org www.upmc-cbn.org May 13, 2009 The Use of Antivirals for 2009 H1N1 Influenza Virus Infection By Ann Norwood, MD, Brooke Courtney, JD, MPH, Eric Toner, MD, and Amesh Adalja, MD Use

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)

TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) SENATE HELP COMMITTEE May 17, 2011 Good morning Chairman

WHO GLOBAL ACTION PLAN FOR INFLUENZA VACCINES

WHO GLOBAL ACTION PLAN FOR INFLUENZA VACCINES SURVEY QUESTIONNAIRE A.1. Introduction The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 as a ten year initiative to address the anticipated

Immunizations: An Overview. Sutter Health May 9, 2017 John Apostolo, PharmD, MBA Heidi Rens, PharmD

Immunizations: An Overview Sutter Health May 9, 2017 John Apostolo, PharmD, MBA Heidi Rens, PharmD Sutter Health: System Overview 2 Agenda Sutter Health Overview Sutter Health Vaccine overview Clinical

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do

Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do Based on current data and information from the Centers for Disease Control (CDC) and the U.S. Department Health and Human Services

Business Continuity and Crisis Management. Cardinal Health s Approach

Business Continuity and Crisis Management Cardinal Health s Approach Welcome We don t have ALL the answers Opportunity to share ideas Discussion around how we can work together to help prepare our communities,

CDC DIRECTOR JOINS NATION S TOP HEALTH EXPERTS TO URGE AMERICANS TO SEEK INFLUENZA AND PNEUMOCOCCAL VACCINATIONS THIS FALL AND WINTER

Contact: Jennifer Corrigan 732-382-8898 732-742-7148 (Cell phone) Victoria Amari 212-886-2248 718-413-6491 (Cell phone) CDC DIRECTOR JOINS NATION S TOP HEALTH EXPERTS TO URGE AMERICANS TO SEEK INFLUENZA

Influenza-Associated Hospitalization and Death Surveillance: Dallas County

Influenza-Associated Hospitalization and Death Surveillance: Dallas County 2009 2015 Sonya Hughes, MPH, CPH Epidemiology Surveillance Coordinator July 22, 2015 Dallas County Health and Human Services Overview:

GSK s Adjuvanted Influenza Vaccines The Taming of the Flu

GSK s Adjuvanted Influenza Vaccines The Taming of the Flu JITMM, Bangkok, October 2008 Bruce L. Innis, MD Global Clinical Research and Development GlaxoSmithKline Biologicals 1 Annual Burden of Influenza

Immunization and Vaccines

Immunization and Vaccines A parental choice Dr. Vivien Suttorp BSc, MPH, MD, CCFP, FCFP Lead Medical Officer of Health South Zone, Alberta Health Services November 7, 2013 Overview Facts about vaccines

Global Influenza Vaccine Market: Industry Analysis & Outlook

Industry Research by Koncept Analytics Global Influenza Vaccine Market: Industry Analysis & Outlook ----------------------------------------- January 2017 1 Executive Summary Influenza, also known as flu,

Final Results Report. National Foundation for Infectious Diseases (NFID) 2015 Influenza/Pneumococcal News Conference

Final Results Report National Foundation for Infectious Diseases (NFID) 2015 Influenza/Pneumococcal News Conference Thursday, September 17, 2015 National Press Club, Washington, DC Keeping the Nation Flu-Focused:

Influenza Clinical Bulletin # 3: October 8, 2009 Vaccination Guidelines for Patients for Influenza

The purpose of this document is to provide NYP providers with the most current recommendations regarding influenza vaccination for their patients. It is important to recognize that guidance reflects optimal

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

Influenza Pandemic (H1N1) 2009

Influenza Pandemic (H1N1) 2009 7 th Congress on Communicable Diseases Lisboa 29 January 2010 World Health Organization Overview Since April 2009, first influenza pandemic of 21 st century underway Most

Frequently Asked Questions About the Flu Vaccine Policy

Frequently Asked Questions About the Flu Vaccine Policy How has the CHWC new flu vaccine policy changed since last year? CHWC s new flu vaccine policy requires all CHWC employees, volunteers, medical staff,

How do I comply with the Influenza Control Program Policy this year?

Influenza Control Program Frequently Asked Questions Influenza Vaccine Influenza or the flu can be a serious contagious disease, which is spread by droplet transmission through close contact with an infected

Disclosures. No support One off-label recommendation

Seasonal Influenza John B. Murphy, MD Professor of Medicine and Family Medicine Warren Alpert Medical School of Brown University Executive Vice President for Physician Affairs, Lifespan 8/21/14 Disclosures